--- a
+++ b/clusters/9knumclustersv2/clust_1260.txt
@@ -0,0 +1,33 @@
+History of infusion reactions to any component/excipient of PRS-.
+Known hypersensitivity to any study related agent excipient(s)
+History of hypersensitivity to durvalumab or any excipient
+History of hypersensitivity to durvalumab or any excipient
+History of severe hypersensitivity to nivolumab, cyclophosphamide, fludarabine, interleukin-, or any excipient
+History of hypersensitivity to durvalumab or any excipient
+History of hypersensitivity to durvalumab or any excipient
+Known hypersensitivity to ST (DOTA biotin) or any excipient.
+History of hypersensitivity to durvalumab or any excipient
+History of hypersensitivity to durvalumab or any excipient
+Known allergy or hypersensitivity to intraperitoneal (IP) or any excipient
+History of hypersensitivity to durvalumab or any excipient
+Hypersensitivity to any of the investigational agents under test, or any excipient of these products
+Have known hypersensitivity to the active substance or to an excipient of the study treatments.
+Known allergy or hypersensitivity to investigational product (IP) or any excipient
+History of hypersensitivity to durvalumab or any excipient
+History of hypersensitivity to durvalumab or any excipient
+History of hypersensitivity to durvalumab or any excipient
+History of hypersensitivity to durvalumab or any excipient
+History of hypersensitivity to MEDI or any excipient
+History of hypersensitivity to MEDI or any excipient.
+History of hypersensitivity to durvalumab or any excipient.
+History of hypersensitivity to durvalumab, guadecitabine (SGI-) or any excipient
+History of hypersensitivity to durvalumab or any excipient
+Have known hypersensitivity to the active substance or to an excipient for a study treatment.
+History of hypersensitivity to durvalumab or any excipient
+History of hypersensitivity to durvalumab or any excipient
+History of hypersensitivity to durvalumab or any excipient
+History of hypersensitivity to durvalumab or any excipient
+Known hypersensitivity to any component of the investigational product (PVX-, durvalumab, or any excipient)
+History of hypersensitivity to durvalumab or any excipient
+History of hypersensitivity to durvalumab or any excipient
+Have known hypersensitivity to anthracycline compounds or any excipient in NC-.